Full text is available at the source.
Abstract
Cannabidiol (CBD) treatment improved cardiac fibrosis and diastolic dysfunction in a mouse model of heart failure with preserved ejection fraction (HFpEF).
- CBD did not reduce cardiac hypertrophy but improved cardiac fibrosis and diastolic function.
- Improvements were linked to a significant reduction in the accumulation of senescent cells.
- CBD treatment lowered systemic cytokine levels, potentially related to the senescence-associated secretory phenotype (SASP).
- CBD suppressed inflammation by preserving the distance between organelles and the integrity of Mitochondria-Endoplasmic Reticulum Contact Sites (MERCSs).
- CBD is suggested to modulate MERCSs communication to influence senescence and inflammation in HFpEF.
Simplified